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Abstract
Protein misfolding cyclic amplification (PMCA) provides faithful replication of mammalian prions in vitro and has numerous
applications in prion research. However, the low efficiency of conversion of PrP
C into PrP
Sc in PMCA limits the applicability of
PMCA for many uses including structural studies of infectious prions. It also implies that only a small sub-fraction of PrP
C
may be available for conversion. Here we show that the yield, rate, and robustness of prion conversion and the sensitivity of
prion detection are significantly improved by a simple modification of the PMCA format. Conducting PMCA reactions in the
presence of Teflon beads (PMCAb) increased the conversion of PrP
C into PrP
Sc from ,10% to up to 100%. In PMCAb, a
single 24-hour round consistently amplified PrP
Sc by 600-700-fold. Furthermore, the sensitivity of prion detection in one
round (24 hours) increased by 2-3 orders of magnitude. Using serial PMCAb, a 10
12-fold dilution of scrapie brain material
could be amplified to the level detectible by Western blotting in 3 rounds (72 hours). The improvements in amplification
efficiency were observed for the commonly used hamster 263K strain and for the synthetic strain SSLOW that otherwise
amplifies poorly in PMCA. The increase in the amplification efficiency did not come at the expense of prion replication
specificity. The current study demonstrates that poor conversion efficiencies observed previously have not been due to the
scarcity of a sub-fraction of PrP
C susceptible to conversion nor due to limited concentrations of essential cellular cofactors
required for conversion. The new PMCAb format offers immediate practical benefits and opens new avenues for developing
fast ultrasensitive assays and for producing abundant quantities of PrP
Sc in vitro.
Citation: Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, et al. (2011) Highly Efficient Protein Misfolding Cyclic Amplification. PLoS
Pathog 7(2): e1001277. doi:10.1371/journal.ppat.1001277
Editor: David Westaway, University of Alberta, Canada
Received August 30, 2010; Accepted January 7, 2011; Published February 10, 2011
Copyright:  2011 Gonzalez-Montalban et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by by NIH grant NS045585 to IVB, Baltimore Research and Education Foundation and the Beatriu de Pinos Fellowship to NGM
with the support of the Commission for Universities and Research of the Department of Innovation, Universities and Enterprise of the Government of Catalonia.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: A provisional patent application was submitted by the institution to which authors are affiliated.
* E-mail: Baskakov@umaryland.edu
. Both authors contributed equally to this work.
Introduction
Protein misfolding cyclic amplification (PMCA)
2 provides
faithful amplification of mammalian prions in vitro and, since its
introduction in 2001 [1], has become an important tool in prion
research. To date, PMCA provides the most sensitive approach for
detecting miniscule amounts of prion infectivity [2–5], including
detection of prions in blood or peripheral tissues at preclinical
stages of the disease [6–8]. In recent studies, PMCA was employed
for generating infectious prions (PrP
Sc) in vitro de novo in crude brain
homogenate [9], and for producing infections prions from the
cellular prion protein (PrP
C) purified from normal mammalian
brains [10] and recombinant PrP (rPrP) produced in E. coli [11].
Furthermore, PMCA has been used for identifying cofactors that
are involved in prion replication [12–15] and assessing the impact
of glycosylation on replication of prion strains [16]. PMCA has
also been utilized for assessing the prion transmission barrier
[17,18], prion interference [5] and adaptation to new hosts [19].
PMCA reactions consist of two alternating steps: incubation and
sonication. Sonication fragments PrP
Sc particles or fibrils into
smaller pieces, a process that that is believed to result in the
multiplication of active centers of PrP
Sc growth. During the
incubation step, small PrP
Sc particles grow by recruiting and
converting PrP
C molecules into PrP
Sc.
While the discovery of PMCA has provided new opportunities
for exploring the prion replication mechanism, the low yield of
PrP
Sc has limited its utility for structural studies. Furthermore, the
efficiency of amplification in PMCA varies dramatically depending
on minor variations in experimental parameters, including those
that are difficult to control, such as the age of the sonicator’s horn
and individual patterns of horn corrosion. Previous strategies for
improving the efficiency of PMCA focused on increasing the
number of cycles within a single PMCA round [2] or increasing
the substrate concentration by using a normal brain homogenate
(NBH) from transgenic mice overexpressing PrP
C [20,21]. Here
we describe a new PMCA format that employs beads (referred to
as PMCAb). Supplementing the reaction with beads resulted in
remarkable improvements in the yield, rate and robustness of
prion conversion, as well as in the sensitivity of prion detection.
This simple modification of the PMCA format enables fast and
efficient production of high quantities of PrP
Sc. This result also
shows that the low yield observed previously has not been due to a
lack of PrP
C susceptible to conversion, nor has it been limited by
cellular cofactors.
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Beads significantly improve the yield and rate of PMCA
reactions
In the past, we found that beads with a diameters of 1.59 mm
(referred to as small or S) or 2.38 mm (referred to as large or L)
significantly accelerated the formation of amyloid fibrils of rPrP in
vitro [22]. Here, we tested whether beads have any effects on the
rate of prion amplification in PMCA. In standard PMCA
(sonication for 30 sec every 30 min, 48 cycles total, no beads),
the typical yield of conversion of PrP
C into PrP
Sc was
approximately 10% as judged by Western blotting (Fig. 1A). This
amplification yield was consistent with previous studies on
amplification of the 263K strain. In the presence of beads,
however, the conversion yield improved significantly and ap-
proached 100% when 3 large or 5 small beads were used (Fig. 1A).
The kinetics of PrP
Sc amplification monitored by Western
blotting revealed that in the absence of beads the newly generated
PrP
Sc was detected by the 16
th cycle, whereas in the presence of
beads it already was seen by the 8
th cycle (Fig. 1B). Furthermore,
in the presence of beads the reaction reached a plateau in only 24
cycles and produced a much higher yield (Fig. 1B). These results
illustrated that beads with diameters of 1.59 or 2.38 mm improved
both the yield and the rate of 263K conversion. When beads of
submillimeter diameter (800, 400, 200 or 100 mm, see Methods)
were used instead, no noticeable increase in PrP
Sc amplification
was observed (data not shown).
PMCAb amplifies prion infectivity
To test whether the products of PMCAb were infectious, the
reactions were seeded with 10
4-diluted 263K brain material and
subjected to amplification in the presence or absence of beads for 6
rounds of 48 cycles each. The products of each round were diluted
10-fold into fresh NBH for the subsequent round. The PMCA
products from the final round were then diluted an additional 10-
fold prior to inoculation of 50 ml per animal. The final dilution of
the initial 263K brain material was 10
10 fold. In our laboratory the
concentration of 263K scrapie in the brains of hamsters in the late
stages of symptomatic disease is consistently between 1 and
2610
10 Infectious Dose50/g of brain [23]. In the absence of
amplification, a 10
10 dilution of 263K brain would contain 1
ID50/ml giving a probability of infection of 0.05 from a 50 ml
inoculation [23]. Nevertheless, all animals inoculated with PMCA
products formed in the presence or absence of beads developed
clinical disease with the mean value of endpoint 108.663.9 or
114.266.3 days post inoculation, respectively (Fig. 2, groups 4 and
5, respectively). Incubation time endpoints were determined
empirically as described in the methods and [23]. The reference
group inoculated with 10
4-diluted 263K brain reached the
endpoint by 110.567.5 days (Fig. 2, group 1). Bioassays of two
263K brain homogenates sonicated for 48 PMCA cycles (1 round)
in the absence of a substrate revealed that sonication of PrP
Sc per
se did not notably change its infectivity level regardless of whether
beads were present or absent during the sonication cycles (Fig. 2,
groups 2 and 3, respectively). Similar amounts of PrP
Sc were found
in the brains from all animal groups (Fig. S1).
The bioassay experiment confirmed that prion infectivity is
amplified in PMCAb. Without a titration experiment, it is difficult
to establish accurate infectivity titers of PMCA or PMCAb
products. Nevertheless, considering that group 5 gave the same
incubation times as group 1, even though the amplification
products were diluted an additional 10-fold prior to inoculation,
the infectivity dose of PMCAb products appeared to be 10-fold
higher than the dose in 10
4-diluted 263K brain material.
The sensitivity of PrP
Sc detection is improved in PMCAb
To test whether the application of beads improves the detection
limit, serially diluted 263K brain homogenate was used to seed the
PMCA reactions that consisted of 48 cycles. In the absence of
beads, seeding with 10
3-fold and with 10
4-fold diluted scrapie
brains gave sufficient amplification of PrP
Sc to be detected by
Western blotting. In the presence of beads, however, the reactions
seeded with 10
6-fold diluted 263K brains showed consistent,
reproducible amplification for subsequent detection by Western
blotting (Fig. 3). Frequently, sufficient amplification of PrP
Sc for
detection by Western blotting was observed in the reactions with
beads seeded with 10
7-fold diluted scrapie brains. Therefore,
within 48-cycle PMCA, beads improved the sensitivity of detection
by at least 2 or 3 orders of magnitude. To rule out the possibility of
the PrP
Sc formation de novo, 32 unseeded reactions were
Figure 1. Beads improve the yield and rate of PrP
Sc conversion.
(A) 263K scrapie brain material was diluted 10
3-fold into 10% normal
brain homogenate (NBH) and subjected to 48 PMCA cycles in the
absence of beads (lane 1) or presence of 1, 2, 3, 4 or 5 small beads (S,
lanes 2–6) or 1, 2 or 3 large beads (L, lanes 7–9). 10% NBH loaded at
100%, 75%, 50% or 25% amounts were used to estimate the
amplification yield (lanes 10–13, respectively). (B) 263K scrapie brain
material was diluted 10
3-fold into 10% NBH and subjected to 4, 8, 16, 24
or 48 PMCA cycles in the absence of beads (lanes 2–6) or presence of 5
small beads (lanes 7–11). Prior to electrophoresis, samples were
digested with Proteinase K (PK) as indicated.
doi:10.1371/journal.ppat.1001277.g001
Author Summary
Protein misfolding cyclic amplification (PMCA) provides
faithful replication of mammalian prions in vitro. While
PMCA has become an important tool in prion research, its
application is limited because of low yield, poor efficiency
and, sometimes, stochastic behavior. The current study
introduces a new PMCA format that dramatically improves
the efficiency, yield, and robustness of prion conversion in
vitro and reduces the time of the reaction. These
improvements have numerous implications. The method
opens new opportunities for improving prion detection
and for generating large amounts of PrP
Sc in vitro.
Furthermore, the results demonstrate that in vitro conver-
sion is not limited by lack of convertible PrP
C nor by
concentrations of cellular cofactors required for prion
conversion.
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(sPMCAb). None of them showed PK-resistant material on
Western blotting (Fig. S2).
To estimate quantitatively the PrP
Sc amplification fold achieved
in a single PMCAb round, we employed dot blotting as it provides
a better linear response within a broader range of PrP
Sc
concentrations than the Western blotting (Fig. S3). The PMCAb
reactions seeded with 10
4-, 10
5-, or 10
6-diluted 263K brain were
found to produce reliable amplification by ,75-, 300-, and 635-
fold within 48 cycles, respectively (Fig. 3B). An increase in
amplification fold at higher dilutions of seeds suggests that the
effect of beads was most beneficial at high PrP
C to PrP
Sc ratios,
where the reaction is no longer limited by the concentration of a
substrate and/or cofactors.
To estimate the PrP
Sc amplification fold using an alternative
approach, sPMCA reactions consisted of three rounds were
performed with the dilution factors between the rounds ranging
from 1:10 to 1:1000. In the absence of beads, we observed a
gradual decrease in the signal intensity as a function of PMCA
round at dilutions of 1:20 indicating that the amplification fold in
each round was slightly lower than 20 (Fig. S4). In the presence of
beads, however, the signal was stable at 1:100 dilution but decayed
at 1:1000 dilution, suggesting that the amplification fold in each
round was higher than 100 but less than 1000 (Fig. S4). This
experiment confirmed that up to several hundred fold amplifica-
tion could be achieved in one PMCAb round consisted of 48
cycles, if the reaction is not limited by substrate and cofactors.
Detection of minute amounts of PrP
Sc
In previous studies, sPMCA of serially diluted 263K brain
homogenate was used to determine the last dilution that still
contained PrP
Sc particles [2]. Three out of four reactions seeded
with 10
12-diluted 263K brain material were found to be positive,
while five to seven sPMCA rounds, each consisting of 144 cycles,
were required to amplify 10
12-diluted 263K to levels detectible by
Western blotting [2]. To test the effectiveness of PMCAb in
amplifying minute quantities of PrP
Sc, 263K brain homogenate
was serially diluted up to 10
14-fold and then amplified in sPMCAb,
where each round consisted of 48 cycles. 10
12-diluted 263K brain
material was detected in 4 out of 8 reactions in the third round
(Fig. 4A). An increase in number of rounds to six did not increase
the percentile of positive reactions seeded with 10
12-diluted 263K
brain nor did it reveal any positive signals in reactions seeded with
10
14-diluted 263K brain (Fig. 4A). 10
10-diluted 263K brains
showed a positive signal in all independent reactions (Fig. 4A).
Non-seeded reactions or reactions seeded with NBH from old
animals showed no positive signals in PMCAb (Fig. 4B). These
results are consistent with the previous studies where brain
material diluted 10
12-fold detected PrP
Sc and showed stochastic
behavior [2] consistent with a limiting dilution of the signal [24].
In the current experiments, PMCAb achieved the same level of
sensitivity as PMCA in 1/7
th of the time and with no evidence of
spontaneous conversion from NHB substrate.
Beads improve the amplification rate of a synthetic prion
strain
To test whether the positive effect of beads on prion
amplification was limited to 263K, we used a synthetic prion
Figure 2. Bioassay of PMCA products. Incubation time to terminal
disease stage in individual animals (circles) and in animal groups
represented as mean 6 S.D. (black bars). Animals were inoculated with
10
24-fold diluted 263K brain homogenate (group 1); 10
24-fold diluted
263K brain homogenate sonicated for 48 cycles (a single PMCA round)
in the absence of beads (group 2) or presence of 3 large beads (group
3) in the absence of NBH; and 10
24-diluted 263K brain homogenate
subjected to six serial PMCA rounds in the absence of beads (group 4)
or presence of 3 large beads (group 5) using 1:10 dilutions between
rounds. After serial PMCA, the amplification products were diluted an
additional 10-fold to obtain 10
10-fold dilutions of the original seeds for
inoculating groups 4 and 5.
doi:10.1371/journal.ppat.1001277.g002
Figure 3. Beads improve the sensitivity of PrP
Sc detection. (A)
263K scrapie brain material was serially diluted 10
4-, 10
5-, 10
6-o r1 0
7-
fold into 10% NBH, subjected to 48 PMCA cycles in the absence of
beads (lanes 3,5) or presence of five small beads (lanes 4,6,7,8) and
digested with PK. Undigested 10% NBH (lanes 1,2) was loaded as a
reference. (B) PrP
Sc amplification in 48 cycles of PMCA conducted with
five small beads for 263K scrapie brain material serially diluted 10
4-, 10
5-
or 10
6-folds as analyzed by dot blotting. The data represent average
and standard deviation of three independent PMCA reactions. The
amplification fold was calculated using calibration curve in Fig. S3.
doi:10.1371/journal.ppat.1001277.g003
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peculiar amplification behavior in PMCA [25]. Previously we
found that amplification efficiency of SSLOW varied significantly
from preparation to preparation of NBH and that it had a much
more unstable amplification behavior than 263K. For instance,
SSLOW failed to amplify even in those preparations of NBHs,
where 263K showed high amplification rates. In such preparations
of NBHs, the amplification fold for SSLOW was found to be lower
than the 10-fold dilution factor used for serial PMCA. Therefore,
in the absence of beads, SSLOW PrP
Sc was no longer detectable
by Western blotting after the first round of PMCA (Fig. 5, lanes 3–
5). In the presence of beads, however, the amount of SSLOW
PrP
Sc remained stable during serial PMCAb if the reactions were
seeded with 10
3-fold diluted SSLOW brain homogenates (Fig. 5,
lanes 6–8), or increased if 10
4-fold dilutions were used for seeding
(Fig. 5, lanes 13-15). These results illustrate that the positive effect
of beads is not limited to 263K and that beads improved the
robustness of PMCA for a strain with poor amplification behavior.
Beads counteract the negative effect of recombinant PrP
In previous studies, recombinant PrP (rPrP) was found to inhibit
amplification of PrP
Sc in PMCA [16]. To test whether the
inhibitory effect can be rescued by addition of beads, serial PMCA
was performed in the absence or presence of 5 mg/ml Syrian
hamster full-length rPrP folded into a a-helical conformation. In
the absence of beads, rPrP was found to suppress the amplification
of 263K (Fig. 6, lanes 10–12). The addition of beads, however,
restored the amplification rate of 263K to the level observed in the
absence of rPrP and beads (Fig. 6, compare lanes 13–15 to 3–5).
However, this amplification level was lower than those observed in
the presence of beads without rPrP (Fig. 6, lanes 6–8).
Species-specificity is preserved in PMCAb
Prion amplification in PMCA was previously shown to exhibit
species specificity that faithfully reflects the transmission barrier
observed in animals [17,18]. Considering that beads were found to
improve significantly the amplification efficiency, we were
Figure 4. Amplification of minute amounts of PrP
Sc in PMCAb. (A) 263K brain material was serially diluted 10
10-, 10
12-, or 10
14-fold and
subjected to sPMCAb amplification in the presence of 3 large beads for 6 rounds as indicated (each round consists of 48 sonication cycles, 10-fold
dilutions were used for subsequent rounds). Amplification in three independent experiments (A, B, and C) are shown. (B) Up to six rounds of PMCAb
in non-seeded NBHs (reactions A and B) or in NBHs seeded with 10 ml of 10% NBH prepared from 661 days old Syrian Hamsters (reactions C and D)
were performed as negative controls. Undigested 10% NBH is provided as a reference.
doi:10.1371/journal.ppat.1001277.g004
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in PMCAb. To address this question, two hamster strains, 263K
and SSLOW were used to seed PMCA reactions in mouse NBHs.
Consistent with the previous results, beads improved the
conversion yield for both strains when they were amplified in
Syrian hamster NBH (Fig. 7A,B). However, when 263K or
SSLOW were diluted with mouse NBH no detectible amplifica-
tion was observed for at least three serial PMCA rounds in the
presence or absence of beads (Fig. 7A,B). A control experiment
revealed that mouse RML strain could be amplified in mouse
NBH (data not shown, and Fig. 8B). Therefore, the lack of
detectible amplification of hamster strains in serial PMCA in
mouse NBH confirmed that the presence of beads does not
eliminate the species barrier. Taken together, these results
illustrate that significant improvements in amplification efficiency
do not come at the expense of amplification specificity.
Effect of bead material on efficiency of amplification
To test whether efficiency of amplification depends on the bead
material, beads made from eight different materials including
Teflon beads purchased from two companies were used for
amplification of 10
5- fold diluted 263K or 10
4- fold diluted RML
(Fig. 8A,B). Beads made from Teflon and acetal showed the best
amplification efficiency for both strains. Nylon and EPDM beads
showed very good performance in amplifying RML, but were less
efficient for 263K. Notably, the ranking orders in amplification
efficiency for different materials appeared to be strain- or species-
dependent. The detailed relationship between the bead material
and their efficiencies to amplify different scrapie strains or strains
from different species will be explored in future studies.
Sonication with beads fragments amyloid fibrils of rPrP
into small pieces
To gain insight into the effect of beads on prion amplification, we
tested whether beads affect the fragmentation efficiency of PrP
aggregates during sonication. Amyloid fibrils produced from rPrP
were sonicated in the presence or absence of beads, and the size of
fibrillar fragments was analyzed using atomic force microscopy
(AFM) imaging. Consistent with our previous studies [26],
sonication was found to break fibrils into smaller fragments
(Fig. 9A,B). Sonication in the presence of beads, however, reduced
the size of fibrillar fragments even more producing smaller particles
(Fig. 9C,D). In fact, AFM imaging revealed that after sonication
with beads, the fibrillar fragments appeared as small oligomers.
Discussion
The current studies demonstrated that the yield and the rate of
prion conversion in PMCA can be substantially improved by
including beads. Remarkably, substantial improvements in the
amplification efficiency and robustness did not come at the cost of
prion replication specificity. While beads were found to increase
the amplification rate of two hamster strains in hamster NBHs, no
detectible amplification of these strains were observed in mouse
NBHs within three rounds. This shows that the species specificity
was preserved (Fig. 7). Furthermore, beads were found to help
counteract the negative effect of rPrP on amplification. It is
tempting to speculate that the PMCAb format will help to improve
the sensitivity of prion detection in body fluids such as blood or
urine that might contain inhibitory compounds. Considering
substantial enhancement in amplification yield, efficiency and
robustness, PMCAb is a promising new platform for developing
sensitive and rapid tests for prions, and producing PrP
Sc in vitro for
structural studies.
The effect of beads on prion amplification can be explained by
several mechanisms. Using amyloid fibrils produced from rPrP, we
showed that sonication in the presence of beads effectively
fragmented rPrP fibrils into pieces that were substantially smaller
than those observed in the absence of beads (Fig. 9). This result
suggests that beads might improve the efficiency of PrP
Sc
fragmentation. Consistent with this mechanism, beads were found
to enhance significantly the amplification efficiency of SSLOW
PrP
Sc, a strain which is deposited in the form of large plaques [25].
Sonication may not only fragment PrP
Sc particles but could also
irreversibly damage or denature PrP
Sc and/or PrP
C. We observed
that during sonication, the beads rose from the bottom of the tubes
and vibrated in the reaction mixtures. Perhaps, the presence of
beads helps to redistribute the cavitation energy of bubbles into the
much ‘‘softer’’ energy of mechanical vibration, making the
conditions for breaking PrP
Sc particles more optimal.
In addition to more efficient fragmentation of PrP
Sc particles,
the effect of beads could be attributed to a breakage of cellular
debris and an increase in the accessibility of PrP
C and/or cellular
cofactors essential for conversion. Considering that different
strains or strains from different species might utilize a variety of
cellular cofactors of different chemical natures [13], optimizing
PMCA amplification might require a different bead material for
some strains. Nevertheless, it is currently not known whether any
of the proposed mechanisms provides an actual physical
explanation for the effect of beads, which at this time should be
Figure 5. Beads improve the amplification efficiency of SSLOW.
SSLOW scrapie brain material was diluted 10
3-fold (lanes 1–8) or 10
4-
fold (lanes 9–15) into 10% NBH, subjected to serial PMCA in the absence
or presence of 3 small beads, as indicated, and digested with PK. Each
PMCA round consisted of 48 cycles; the material amplified in each
round was diluted 10-fold into 10% NBH for the next PMCA round.
Undigested 10% NBH (lane 1) loaded at 1/10
th the amount of the
digested samples is provided as a reference.
doi:10.1371/journal.ppat.1001277.g005
Figure 6. Beads counteract the negative effect of rPrP on PrP
Sc
amplification. 263K scrapie brain material was diluted 10
3-fold into
10% NBH and subjected to a serial PMCA in the absence or presence of
a-rPrP (5 mg/ml) and absence or presence of 3 small beads, as indicated.
Each PMCA round consisted of 48 cycles; the material amplified in each
round was diluted 10-fold into 10% NBH for the next PMCA round.
Undigested 10% NBH (lane 1) loaded at 1/10
th the amount of the
digested samples is provided as a reference.
doi:10.1371/journal.ppat.1001277.g006
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remains to be elucidated in future studies, the PMCAb format
offers immediate practical benefits.
In previous studies, only a small subfraction of PrP
C could be
converted into PrP
Sc in PMCA, which raised concerns that only a
fraction of PrP
C is susceptible to conversion. In an attempt to
improve the conversion yield, an increase in the number of PMCA
cycles [2] or the application of NBH from transgenic mice with
high expression of endogenous PrP
C was employed [20,21].
However, it is unclear whether these approaches can favorably
change the balance between productive conversion and the
competing reactions, which might include spontaneous oxidative
modification of PrP
C [27], the self-cleavage of PrP
C [28] and
unproductive misfolding. Increasing the time of a PMCA round or
the concentration of a substrate is likely to impact both productive
and unproductive pathways. The current work shows that an
alternative approach that relies on a simple technical modification
in the reaction format could be much more rewarding than
biochemical approaches. An increase in the conversion yield
suggested that beads selectively accelerate the rate of productive
conversion of PrP
C into PrP
Sc without affecting competing
reactions. Remarkably, a substantial fraction if not 100% of PrP
C
could be converted into PrP
Sc in PMCAb (Fig. 1). This result
argues that the amplification yield is not limited to a small
subfraction of PrP
C susceptible to conversion or by cellular
cofactors involved in the conversion reactions.
The most beneficial effect of beads on amplification was
observed at high seed dilutions, i.e. at high PrP
C/PrP
Sc ratios
when the supply of PrP
C was unlimited (Fig. 3 and Fig. S4). In this
case, beads improved the sensitivity of detection by at least 2 or 3
orders of magnitude. When seeded with high concentrations (10
3
or 10
4-dilution of scrapie brain material), the differences in
amplification yield between PMCA and PMCAb was approxi-
mately 10-fold (Fig. 1). A 10-fold difference was also consistent
with the difference in mean incubation time observed between the
two groups after inoculation (Fig. 2). However, this difference must
Figure 7. PMCA with beads preserves species barrier. (A) SSLOW scrapie brain material was diluted 10
3-fold into 10% hamster or 10% mouse
NBH, subjected to serial PMCA in the absence or presence of 3 large beads, as indicated, and digested with PK. Undigested 10% NBH (lane 1) is
provided as a reference. (B) 263K scrapie brain material was diluted 10
3-fold into 10% hamster or 10% mouse NBH, subjected to serial PMCA in the
absence or presence of 3 large beads, as indicated, and digested with PK. Undigested 10% NBH (lane 1) is provided as a reference. Each PMCA round
consisted of 48 cycles; the material amplified in each round was diluted 10-fold into 10% NBH for the next PMCA round.
doi:10.1371/journal.ppat.1001277.g007
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measurement. Regardless, the bioassay confirmed that PMCAb
amplifies prion infectivity at least equivalently to PMCA.
In our experience, prion amplification in PMCA is very sensitive
to technical settings such as the precise position of a tube within the
microplate horn, i.e. the distance of a tube from horn’s surface and
its center; the age of the sonicator’s horn; the tube’s shape.
Furthermore, aging of sonicatior’s horn and individual patterns of
horn erosion with age cause time- and position-dependent
variations in sonication power. As a result, it is difficult to obtain
consistent amplification of PrP
Sc in experiments performed in
different sonicators or even using the same sonicator as it ages. For
instance, the differences in the yield of PrP
Sc amplification seen in
lanes B6 and A1 in Fig. 1 were attributed to the aging of the
sonicator’s horn, as both these experiments were performed using
the same sonicator but at a slightly different age. In our experience,
Teflon beads significantly improve the robustness of PMCA making
prion amplification less sensitive to technical variations, which are
difficult to control. The new format should help to establish a
PMCA-based approach for assays of prion infectivity.
Figure 8. Effect of bead material on efficiency of amplification. (A) 263K scrapie brain material was serially diluted 10
5-fold into 10% hamster
NBH and subjected to 48 PMCA cycles in the presence of two beads made from Teflon (purchase from McMaster-Carr – lane 2, or Small Parts – lane 3),
stainless steel 440C, neoprene, nylon, EPDM, nitrile, stainless still 302, or acetal, as indicated. Prior to electrophoresis, samples in lanes 2–10 were
digested with PK. Undigested 10% hamster NBH (lane 1) was loaded as a reference. Without PMCA, 10
5- fold diluted 263K brain material was not
detectable by Western blotting (not shown). (B) RML scrapie brain material was serially diluted 10
4-fold into 10% mouse NBH and subjected to 48
PMCA cycles in the absence of beads (lane 3) or presence of two beads made from Teflon (purchase from Small Parts – lane 4), neoprene, nylon,
EPDM, nitrile, stainless still 302, or acetal, as indicated. Prior to electrophoresis, samples in lanes 2–10 were digested with PK. Undigested 10% mouse
NBH (lane 1) was loaded as a reference.
doi:10.1371/journal.ppat.1001277.g008
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Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Maryland, Baltimore (Assurance
Number A32000-01; Permit Number: 0309001).
Protein misfolding cyclic amplification
Healthy hamsters were euthanized and immediately perfused
with PBS, pH 7.4, supplemented with 5 mM EDTA. Brains were
dissected, and 10% brain homogenate (w/v) was prepared using
ice-cold conversion buffer and glass/Teflon tissue grinders cooled
on ice and attached to a constant torque homogenizer (Heidolph
RZR2020). The brains were ground at low speed until
homogeneous, then 5 additional strokes completed the homoge-
nization. The composition of conversion buffer was as previously
described [29]: Ca
2+-free and Mg
2+-free PBS, pH 7.5, supple-
mented with 0.15 M NaCl, 1.0% Triton and 1 tablet of Complete
protease inhibitors cocktail (Roche, Cat. # 1836145) per 50 ml of
conversion buffer. The resulting 10% normal brain homogenate in
conversion buffer was used as the substrate in PMCA reactions.
To prepare seeds, 10% scrapie brain homogenates in PBS were
serially diluted 10- to 10
14-fold, as indicated, in the conversion
buffer and 10 ml of the dilution were used to seed 90 ml of NBH in
PMCA. Samples in 0.2 ml thin-wall PCR tubes (Fisher, Cat. #
14230205) were placed in a rack fixed inside Misonix S-3000 or S-
4000 microplate horn, filled with 300 ml water. Two coils of
rubber tubing attached to a circulating water bath were installed
for maintaining 37uC inside the sonicator chamber. The standard
sonication program consisted of 30 sec sonication pulses delivered
at 50% to 70% efficiency applied every 30 min during a 24 hour
period. For PMCA with beads, small (1.58 mm diameter) or large
(2.38 mm diameter) Teflon beads (McMaster-Carr, Los Angeles,
CA) were placed into the 0.2 ml tubes first using tweezers, then
NBH and seeds were added. The following beads from Small Parts
(www.smallparts.com) were tested in Figure 8: PTFE Ball Grade II
(Teflon); Stainless Steel 440C Ball Grade 24; Neoprene Ball;
Nylon Ball; EPDM Ball; Nitrile Rubber Ball; Stainless Steel 302
Ball Grade 100; Acetal Ball Grade I. The diameter of all beads was
2.38 mm except of Stainless Steel 440C Ball, which was 2 mm in
diameter. The following low binding beads showed no effects on
efficiency in PMCA: Silica Beads Low Binding 800 or 400 mm
diameter, and Zirconium Beads Low Binding 200 or 100 mm
diameter (all from OPS Diagnostics LLS, Lebanon, NJ).
In our experience, the amplification efficiency in PMCA
depended strongly on the position of the tube within a microplate
horn, i.e. distance of a tube from horn’s surface to the tube and its
center; and the age of the sonicator’s horn. In the current studies,
several Misonix sonicators were used, all equipped with horns less
Figure 9. AFM imaging of rPrP fibril fragmentation. AFM imaging of intact rPrP fibrils (A) and fibrils sonicated for 30 sec in the absence (B)o r
presence of 5 small beads (C) using sonication conditions identical to those used in PMCA. Scale bars =0.5 mm. (D) Analysis of length, width and
height for intact rPrP fibrils (green circles) and fibrils sonicated in the absence (orange circles) or presence of 5 small beads (red circles).
doi:10.1371/journal.ppat.1001277.g009
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between 1.5 cm and 5 cm from the horn’s center. Nevertheless,
we experienced substantial variations in amplification efficiency in
standard PMCA (no beads), which appear due to differences in the
age of horns, individual patterns of horn corrosion or differences in
the horizontal coordinates of tubes. In the presence of beads, the
amplification was much more robust and showed only minor
variations.
Bioassay and estimation of the incubation times to
disease
Weanling golden Syrian hamsters were inoculated intracere-
brally with 50 ml each using the following inocula: animals of
group 1 were inoculated with 263K brain homogenate diluted
10
4-fold relative to whole brain in PBS, 1% BSA. For groups 2 and
3, 10 ml of 10% 263K scrapie brain homogenate were mixed with
90 ml of PBS and subjected to a sonication procedure equivalent to
a single PMCA round (48 sonication cycles) in the absence of
NBH. Sonication was performed either without beads (for group 2)
or with 3 large beads (for group 3). Then, the sonication products
were diluted 100-fold into PBS, 1% BSA to obtain final dilution of
10
24 relative to whole 263K brain for inoculation. For groups 4
and 5, PMCA reactions were seeded with 10
-4-diluted 263K brain
material, then six serial PMCA rounds were conducted in the
absence of beads (for group 4) or presence of 3 large beads (for
group 5) using 1:10 dilutions between rounds. After the 6
th round
of serial PMCA, the amplification products were diluted an
additional 10-fold into PBS, 1% BSA to obtain final 10
10-fold
dilutions of the initial 263K brain material prior to inoculation.
In hamsters inoculated with the 263K scrapie strain, the
asymptomatic period of infection lasts 60 to 160 days followed by a
stereotypic clinical progression leading to death 2 to 3 weeks later.
Individual symptoms, such as wobbling gait and head bobbing, are
readily recognized but their onset is subtle and subject to large
inter (and even intra) observer variability. Incubation time
determinations are greatly improved by an empirical determina-
tion of endpoint [23]. The adult body weight of asymptomatic or
uninfected hamsters is stable or increases slowly during adulthood
but drops precipitously during symptomatic disease. Hamsters
showing clear signs of early scrapie were individually caged and
weighed daily. The weight history was plotted against time with a
reference endpoint line marking 20% of the maximum weight
registered. Animals were euthanized when their body weights
dropped below 20% of maximum body weight and the incubation
endpoint was taken as the time intercept of the 20% line.
Proteinase K assay
To analyze production of PK-resistant PrP material in PMCA,
15 ml of each sample were supplemented with 2.5 ml SDS and
2.5 ml PK, to a final concentration of SDS and PK of 0.25% and
50 mg/ml respectively, followed by incubation at 37uC for 1 hour.
The digestion was terminated by addition of SDS-sample buffer
and boiling for 10 min. Samples were loaded onto NuPAGE 12%
BisTris gels, transferred to PVDF membrane, and stained with
3F4 or D18 antibody for detecting hamster or mouse PrPs,
respectively.
To analyze scrapie brain homogenates, an aliquot of 10% brain
homogenate was mixed with an equal volume of 4% sarcosyl in
PBS, supplemented with 50 mM Tris, pH 7.5, and digested with
20 mg/ml PK for 30 min at 37uC with 1000 rpm shaking
(Eppendorf thermomixer). The reaction was stopped by adding
2 mM PMSF and SDS sample buffer. Samples were boiled for
10 min and loaded onto NuPAGE 12% BisTris gels. After transfer
to PVDF membrane, PrP was detected with 3F4 antibody.
Quantification of PrP
Sc by dot blotting
To obtain calibration curves for calculating of PMCA fold
amplification, 10% brain homogenate from 263K animals was
sonicated for 1 min and serially diluted into 10% NBH sonicated
for 30 sec. PMCA samples as well as 263K dilutions were digested
with 50 mg/ml PK for 1 h at 37uC. The reaction was stopped by
addition of 2 mM PMSF. All samples were diluted 10-fold in PBS,
and analyzed using a 96-well immunoassay similar to those
previously published [30]. Our procedure employed the Bio-Dot
microfiltration system (Bio-Rad, Hercules, CA) used according to
the instruction manual. 50 ml of diluted samples were loaded into
each well and allowed to bind to a 0.45 mm Trans-Blot
nitrocellulose membrane (Bio-Rad, Hercules, CA). Following
two washes with PBS, the membrane was removed, incubated
for 30 min in 6 M GdnHCl to enable PrP denaturation, washed,
and probed with 3F4 antibody according to the standard
immunoblotting procedure. Chemiluminescent signal from the
membrane was collected with a Typhoon 9200 Variable Mode
Imager (Amersham Biosciences, Piscataway, NJ) and quantified
with ImageQuant software (Amersham Biosciences).
Atomic Force Microscopy imaging of rPrP-fibrils
Full-length hamster rPrP (residues 23-231, no tags) was
expressed and purified as previously described [27,28]. To
prepare fibrils, the fibrillation reactions were conducted in 2M
GdnHCl, 50 mM MES, pH 6.0 at 37uC at slow agitation (,60
rpm) and rPrP concentration of 0.25 mg/ml [31]. 0.2 ml PCR
tubes containing 100 ml solution of rPrP fibrils (10 mg/ml)
dialyzed into 5 mM sodium acetate, pH 5.0, were placed in a
rack fixed on the top of Misonix S-4000 microplate horn filled
with 300 ml water and sonicated in the absence or presence of
five small Teflon beads at 200 W ultrasound power for 30 s.
Then, 5 ml of each sample was placed on a freshly cleaved piece
of mica, incubated for 5 min, washed gently with Milli Q water,
dried on air, and analyzed using a Pico LE AFM system (Agilent
Technologies, Chandler, AZ) equipped with a PPP-NCH probe
(Nanosensors, Switzerland) and operated in tapping mode.
Topography/amplitude images (square size of 2 to 10 mm,
5126512 pixels) were obtained at 1 line/s scanning speed. Tip
diameter was calibrated by obtaining images of 5-nm gold
particles (BBinternational, UK) under the same scanning
conditions. Images were analyzed with PicoScan software
supplied with the instrument. Particle height was calculated
directly from the topography profiles, while width and length
were measured at the half-height and corrected for the tip
diameter. Dimensions of 130–150 particles for each group from
three independent experiments were measured.
Supporting Information
Figure S1 Proteinase K assay of scrapie brain homogenates.
Western blotting of scrapie brain homogenates from animal
groups # 2, 3, 4 and 5. Two brain homogenates per group are
shown. 10% brain homogenates were treated with 20 mg/ml PK
for 30 min at 37C, 3F4 antibody was used for western blotting.
Found at: doi:10.1371/journal.ppat.1001277.s001 (0.16 MB TIF)
Figure S2 PMCAb does not produce PrP
Sc de novo. 10% NBH
was subjected to a three rounds of serial PMCAb (with 3 large
beads) in the absence of seeds and digested with PK. Each PMCA
round consisted of 48 cycles; 10-fold dilutions were used for serial
rounds. 32 independent reactions were analyzed. Undigested 10%
NBH (lane 1) are showed as references.
Found at: doi:10.1371/journal.ppat.1001277.s002 (0.56 MB TIF)
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Sc amplification fold. (A)
263K scrapie brain material was serially diluted into 10% NBH to
the final concentrations of scrapie brain ranging from 10% to
0.0625%, then digested with 50 mg/ml PK for 1 h at 37uC and
analyzed using a 96-well dot blot. The signal intensity was
measured using a Typhoon 9200 Variable Mode Imager and was
found to be linear within the concentrations of scrapie brain
homogenate from 0.0625% to 1% as shown in panel B. This
concentration range was used to estimate the fold amplification of
PrP
Sc in PMCA.
Found at: doi:10.1371/journal.ppat.1001277.s003 (0.33 MB TIF)
Figure S4 Analysis of PrP
Sc fold amplification in serial PMCA.
263K brain material was diluted 10
4-fold into 10% NBH (lane 2)
and subjected to a three rounds of PMCA in the absence of beads
(top panel) or presence of 3 large beads (bottom panel) and
digested with PK. The material amplified in each round was
diluted 10-, 20-, 100-, or 1000-fold into 10% NBH for the next
PMCA round, as indicated. Each PMCA round consisted of 48
cycles. Undigested 10% NBH (lane 1) is provided as a reference.
Found at: doi:10.1371/journal.ppat.1001277.s004 (0.44 MB TIF)
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